Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a... see more

TSX:SVA - Post Discussion

Sernova Corp > This Place is a Ghost Town.
View:
Post by MoneyMouth on Aug 09, 2022 11:17am

This Place is a Ghost Town.

Not a single post for 5 days, wow. That has got to be a new record. However, I feel like I'm overturning a big ol stone by posting and casuing the beetles and ants to scurry all over the place. Anyone there? 

I think we have a pretty clear picture of where we are right now with this stock, albeit tough to accept. We are going to have to sit pretty until atleast the end of the month when Evotec gives us a couple mil, but that'll likely be a "Sell the News" moment. And then after that, some more warrants get excercised in September and we'll get some sort of press release probably being like "Sernova now has a lot of money in the bank" and that'll get sold into as well. 

Our one and only hope for News to move the share price comes in the form of an announcement of a formal Clinical Trial for the thyroid program, but that's supposedly a 2023 thing... and shoot if that doesn't move the needle, then strap yourselves in until 2024 which was is when it is projected that Sernova files the IND for a clinical trial with Evotec's Stem Cells. At that point in time, things could get good. We could actually see $3 at that point. And if you don't sell then, guess what, you're waiting atleast 18 months until results are released where we maybe go to $5 or more. 

Alls I'm saying, is that it is a tough pill to swallow knowing the wait is still about a year and half long, and you are naieve if you think we'll get a "Surprise" inbetween now and then, because there's never "Surprises" with Sernova, you'll see the rumor mill churning months in advance of any "Surprise".
Comment by BioTeck on Aug 09, 2022 12:40pm
Welcome to the club MM. You took the scenic route, but you arrived. Enjoy your stay, it'll be a long one.
Comment by MustangSalley on Aug 09, 2022 10:25pm
Yes welcome to Hotel Sernova ....  you come but you are never allowed to leave .....  Mouth .... I remember when you use to post those funny pics with the captions . But your assessment is bang on . Nothing will happen . Management will be so incompetent that they will extend the February warrants which will be held over shareholders like a hostage for another year.  If they ...more  
Comment by MoneyMouth on Aug 10, 2022 11:42am
Like this?:
Comment by MustangSalley on Aug 10, 2022 12:24pm
Lol ... yup .....   
Comment by BioTeck on Aug 10, 2022 12:55pm
Too bad MM, Spill has you (and everyone else)  by the short and curlies. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities